“Biochemistry Laboratory Shift Based on Common Terminology Criteria in Patients With Advanced Basal Cell Carcinoma Receiving Sonidegib 200 Mg Daily: Results from the 42-Month BOLT Study”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 2, Mar. 2023, p. s181, https://doi.org/10.25251/skin.7.supp.181.